ダウンロード数: 365
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
j.stemcr.2014.10.013.pdf | 2.45 MB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | Li, Hongmei Lisa | en |
dc.contributor.author | Fujimoto, Naoko | en |
dc.contributor.author | Sasakawa, Noriko | en |
dc.contributor.author | Shirai, Saya | en |
dc.contributor.author | Ohkame, Tokiko | en |
dc.contributor.author | Sakuma, Tetsushi | en |
dc.contributor.author | Tanaka, Michihiro | en |
dc.contributor.author | Amano, Naoki | en |
dc.contributor.author | Watanabe, Akira | en |
dc.contributor.author | Sakurai, Hidetoshi | en |
dc.contributor.author | Yamamoto, Takashi | en |
dc.contributor.author | Yamanaka, Shinya | en |
dc.contributor.author | Hotta, Akitsu | en |
dc.contributor.alternative | 李, 紅梅 | ja |
dc.contributor.alternative | 笹川, 典子 | ja |
dc.contributor.alternative | 田中, 道廣 | ja |
dc.contributor.alternative | 天野, 直己 | ja |
dc.contributor.alternative | 櫻井, 英俊 | ja |
dc.contributor.alternative | 山中, 伸弥 | ja |
dc.contributor.alternative | 堀田, 秋津 | ja |
dc.date.accessioned | 2016-04-18T04:58:13Z | - |
dc.date.available | 2016-04-18T04:58:13Z | - |
dc.date.issued | 2015-01-13 | - |
dc.identifier.issn | 2213-6711 | - |
dc.identifier.uri | http://hdl.handle.net/2433/210241 | - |
dc.description | iPS細胞を使った遺伝子修復に成功 --デュシェンヌ型筋ジストロフィーの変異遺伝子を修復--. 京都大学プレスリリース. 2014-11-27. | ja |
dc.description.abstract | Duchenne muscular dystrophy (DMD) is a severe muscle-degenerative disease caused by a mutation in the dystrophin gene. Genetic correction of patient-derived induced pluripotent stem cells (iPSCs) by TALENs or CRISPR-Cas9 holds promise for DMD gene therapy; however, the safety of such nuclease treatment must be determined. Using a unique k-mer database, we systematically identified a unique target region that reduces off-target sites. To restore the dystrophin protein, we performed three correction methods (exon skipping, frameshifting, and exon knockin) in DMD-patient-derived iPSCs, and found that exon knockin was the most effective approach. We further investigated the genomic integrity by karyotyping, copy number variation array, and exome sequencing to identify clones with a minimal mutation load. Finally, we differentiated the corrected iPSCs toward skeletal muscle cells and successfully detected the expression of full-length dystrophin protein. These results provide an important framework for developing iPSC-based gene therapy for genetic disorders using programmable nucleases. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier Inc. | en |
dc.rights | © 2015 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/). | en |
dc.title | Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9 | en |
dc.type | journal article | - |
dc.type.niitype | Journal Article | - |
dc.identifier.jtitle | Stem Cell Reports | en |
dc.identifier.volume | 4 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 143 | - |
dc.identifier.epage | 154 | - |
dc.relation.doi | 10.1016/j.stemcr.2014.10.013 | - |
dc.textversion | publisher | - |
dc.identifier.pmid | 25434822 | - |
dc.relation.url | https://www.kyoto-u.ac.jp/ja/research-news/2014-11-27 | - |
dcterms.accessRights | open access | - |
出現コレクション: | 学術雑誌掲載論文等 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。